Cabozantinib User Reviews & Ratings (Page 2)
Brand names: Cabometyx, Cometriq
Cabozantinib has an average rating of 6.6 out of 10 from a total of 27 reviews on Drugs.com. 56% of reviewers reported a positive experience, while 22% reported a negative experience.
Reviews for Cabozantinib
- Pra...
- Taken for 1 to 6 months
- October 31, 2018
For Renal Cell Carcinoma "Mixed results on multiple mets, some higher ratings while some lower on SUV. No further progression following 4 months of therapy. Major side effects: diarrhea and minor increase in blood pressure."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about cabozantinib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
For Renal Cell Carcinoma "I have been taking Cabometyx for the last seven months, very mild side effects. Oh, no sign of the tumor in my lung. Thank God."